[1]
Dimou, A.T. et al. 2011. Novel Agents in the Management of Pancreatic Adenocarcinoma: Phase I Studies. JOP. Journal of the Pancreas. 12, 2 (Mar. 2011), 114–116. DOI:https://doi.org/10.6092/1590-8577/3335.